FundedIQ
Biotechnology

Alpine Immune Sciences: Funding, Investors & Team (Oct 2026)

Alpine Immune Sciences is an immunotherapy startup focused on developing recombinant, protein-based therapeutic solutions. It was founded on January 23, 2015, and is based in Seattle, Washington.

alpineimmunesciences.com LinkedIn Seattle, United States 101-250 employees
Total raised
$341M
Rounds
3
Latest
Undisclosed round
Nov 2023

Alpine Immune Sciences has raised $341M across 3 funding rounds on record, the most recent an undisclosed round of $150M announced in Nov 2023.

That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Alpine Immune Sciences Company Profile and Key Stats

Total funding raised
$341M
across 3 rounds on record
Funding rounds on record
3
Latest funding round
Undisclosed round
$150M in Nov 2023
Employees
101-250
reported band
Headquarters
Seattle, United States

Latest funding round on record: Nov 2023.

Alpine Immune Sciences Funding Rounds

Date
Round
Amount
Undisclosed round
$150M
Post-IPO Equity
$100M
Post-IPO Equity
$91.0M

Alpine Immune Sciences raised $91.0M in a Post-IPO Equity announced in Sep 2021.

1 years later, a Post-IPO Equity of $100M was announced in Sep 2022.

1.2 years later, an undisclosed round of $150M was announced in Nov 2023.

Alpine Immune Sciences Founders and Leadership Team

Name
Role
Contact
Mitchell Gold
Founder
Locked
Gold Mitchell
CEO
Locked

Contact details for the Alpine Immune Sciences team: 2 of 2 have an email address on file.

Start 14-day free trial →

Alpine Immune Sciences Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M

Alpine Immune Sciences' latest round of $150M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Alpine Immune Sciences in Biotechnology and Seattle

Companies Similar to Alpine Immune Sciences

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Alpine Immune Sciences Funding FAQs

What does Alpine Immune Sciences do?

Alpine Immune Sciences is an immunotherapy startup focused on developing recombinant, protein-based therapeutic solutions. It was founded on January 23, 2015, and is based in Seattle, Washington.

How much funding has Alpine Immune Sciences raised?

Alpine Immune Sciences has raised $341M across 3 rounds on record. The most recent is an undisclosed round of $150M announced in Nov 2023.

When did Alpine Immune Sciences last raise funding?

Alpine Immune Sciences' most recent funding round on record is an undisclosed round of $150M, announced in Nov 2023.

Who founded Alpine Immune Sciences?

FundedIQ lists Mitchell Gold (Founder) at Alpine Immune Sciences.

Who is the CEO of Alpine Immune Sciences?

Gold Mitchell is listed as CEO at Alpine Immune Sciences.

Where is Alpine Immune Sciences headquartered?

Alpine Immune Sciences is based in Seattle, Washington, United States.

How many employees does Alpine Immune Sciences have?

Alpine Immune Sciences is in the 101-250 employee band.

How does Alpine Immune Sciences' funding compare to other Biotechnology startups?

Alpine Immune Sciences' latest round of $150M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Alpine Immune Sciences Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Alpine Immune Sciences is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.